New York, NY / Washington, D.C. - The following is the response of Jeff Stier, director of the National Center's Risk Analysis Division, to the decision of the drug company Chimerix to make an experimental drug, Brincidofovir, available to an ...
READ MORE
Category: Risk Analysis
Despite Scare Stories, Fears About BPA are Unnecessary, by Cherylyn Harley LeBon
READ MORE
Starbucks Applauded for Standing Firm in Defense of GMOs
READ MORE
If You Liked Mayor Bloomberg, You’ll Love Mayor de Blasio
READ MORE
Stier Shorts Out Nanny State Argument to Unplug Kids’ Electronics
READ MORE
Statement of Risk Analysis Division Director Jeff Stier in Response to Chimerix Decision to Make Experimental Drug Brincidofovir Available to Seven-Year-Old Boy
READ MORE
Obama Administration to Insert Global Warming Activism into Dietary Guidelines Mandated by Congress
READ MORE
Los Angeles City Council Votes to Treat Much-Safer E-Cigarettes Just Like Dangerous Tobacco Cigarettes
READ MORE
Project 21 Members Predicted First Lady’s Food Fanaticism
READ MORE
Nanny State Group Questions Michelle Kwan’s Dual Roles as Both Member of the President’s Council on Fitness and Coca-Cola Ambassador
READ MORE
Listen: National Center’s Almasi Shatters Chuck Schumer, Food Babe Claims Over Pennsylvania Airwaves
READ MORE